← Back to headlines
Merck & Co. Advances on Strong Keytruda Sales and Positive Clinical Trials
Merck & Co. saw its stock advance, driven by robust sales of its drug Keytruda and favorable results from recent clinical trials.
18 Feb, 15:17 — 18 Feb, 15:17
ℹOnly 1 source covers this story
